Page breadcrumb nav

VAERS Report 2156783

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: unknown


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2022-02-04
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

nausea; appetite absent/loss of appetite; tight chest/sore tight chest; black diarrhea; feeling sick/feeling sick at the thought of food; chest pain/sore tight chest; fatigue/unusual tiredness; fever; heart palpitations; racing heart (tachycardia); sore when breathing; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority. regulatory number: gb-mhra-webcovid-202202162216032410-exz7h. other case identifier(s): gb-mhra-adr 26611749. a 24 year-old female patient (not pregnant) received bnt162b2 (comirnaty), administration date 04feb2022 (batch/lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. vaccination history included: bnt162b2 (dose 1, single;), for covid-19 immunisation; bnt162b2 (dose 2, single;), for covid-19 immunisation. the following information was reported: diarrhoea (medically significant) with onset feb2022, outcome "not recovered", described as "black diarrhea"; malaise (medically significant) with onset feb2022, outcome "not recovered", described as "feeling sick/feeling sick at the thought of food"; chest pain (medically significant) with onset feb2022, outcome "unknown", described as "chest pain/sore tight chest"; chest discomfort (medically significant) with onset 13feb2022, outcome "not recovered", described as "tight chest/sore tight chest"; nausea (medically significant) with onset 14feb2022, outcome "not recovered", described as "nausea"; decreased appetite (medically significant) with onset 14feb2022, outcome "not recovered", described as "appetite absent/loss of appetite"; fatigue (medically significant) with onset feb2022, outcome "unknown", described as "fatigue/unusual tiredness"; pyrexia (medically significant) with onset feb2022, outcome "unknown", described as "fever"; palpitations (medically significant) with onset feb2022, outcome "unknown", described as "heart palpitations"; tachycardia (medically significant) with onset feb2022, outcome "unknown", described as "racing heart (tachycardia)"; painful respiration (non-serious) with onset feb2022, outcome "unknown", described as "sore when breathing". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: (14feb2022) no - negative covid-19 test. patient has not had symptoms associated with covid-19 patient is not pregnant. patient is not currently breastfeeding. patient has not tested positive for covid-19 since having the vaccine. patient is not enrolled in clinical trial. sore tight chest, sore when breathing. loss of appetite feeling sick at the thought of food. black diarrhea. does your report relate to possible inflammation of the heart (myocarditis or pericarditis) was "yes". no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

Données de laboratoire
test date: 20220214; test name: covid-19 virus test; result unstructured data: test result:no - negative covid-19 test
Liste des symptômes
diarrhoea malaise fatigue nausea chest discomfort chest pain decreased appetite tachycardia palpitations pyrexia sars-cov-2 test painful respiration
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na